TFS Capital’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
– Sell
-12,236
Closed -$65K – 1476
2014
Q1
$65K Sell
12,236
-9,841
-45% -$55.2K ﹤0.01% 1302
2013
Q4
$123K Buy
+22,077
New +$95.2K 0.01% 1378
2013
Q3
– Sell
-207,680
Closed -$885K – 1722
2013
Q2
$885K Buy
+207,680
New +$1.04M 0.04% 652

Other funds holding SGYP

TFS Capital's SGYP Position: Q2 2014 in Review

TFS Capital sold out of Synergy Pharmaceuticals (SGYP) in Q2 2014, closing a stake of 12,236 shares — an estimated $65K sold.

TFS Capital first reported a position in SGYP in Q2 2013 and held it in 3 quarters. The position peaked at $885K in Q2 2013. 86 funds tracked by Wall St. Rank hold SGYP as of Q2 2014.

  • TFS Capital reported no remaining Synergy Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • TFS Capital sold 12,236 Synergy Pharmaceuticals shares in Q2 2014, an estimated $65K.
  • TFS Capital first reported a position in Synergy Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • TFS Capital's Synergy Pharmaceuticals position peaked at $885K in Q2 2013.
  • 86 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.